webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Folate-PEG3-amine

  CAS No.: 710323-40-3   Cat No.: BADC-01525 4.5  

Folate-PEG3-amine is a highly complex biological small molecule that shows great potential in combating various diseases through its precise receptor targeting mechanism. The conjugate, which represents a mixture of folic acid (a valuable vitamin B9 derivative) and polyethylene glycol (PEG), offers unparalleled opportunities for drug delivery systems, cancer treatments and even imaging agents.

Folate-PEG3-amine

Structure of 710323-40-3

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C27H37N9O8
Molecular Weight
615.64

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Folate-PEG3-amine; (S)-1-amino-16-(4-((2-amino-4-hydroxypteridin-6-yl)methylamino)benzamido)-13-oxo-3,6,9-trioxa-12-azaheptadecan-17-oic acid
IUPAC Name
(2S)-5-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethylamino]-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]-5-oxopentanoic acid
Canonical SMILES
C1=CC(=CC=C1C(=O)NC(CCC(=O)NCCOCCOCCOCCN)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N
InChI
InChI=1S/C27H37N9O8/c28-7-9-42-11-13-44-14-12-43-10-8-30-21(37)6-5-20(26(40)41)34-24(38)17-1-3-18(4-2-17)31-15-19-16-32-23-22(33-19)25(39)36-27(29)35-23/h1-4,16,20,31H,5-15,28H2,(H,30,37)(H,34,38)(H,40,41)(H3,29,32,35,36,39)/t20-/m0/s1
InChIKey
GZQSIWKWWBLFGU-FQEVSTJZSA-N

Folate-PEG3-amine, a versatile compound with diverse applications in bioscience and medicine, plays a pivotal role in various cutting-edge advancements. Here are four key applications of Folate-PEG3-amine:

Targeted Drug Delivery: Folate-PEG3-amine stands at the forefront of targeted drug delivery innovations, particularly in cancer therapy. By conjugating therapeutic drugs to Folate-PEG3-amine, scientists can specifically target cancer cells that exhibit elevated folate receptors, thus amplifying treatment effectiveness while mitigating adverse effects. This precision targeting strategy enhances drug accumulation in tumors while minimizing impact on healthy tissues.

Diagnostic Imaging: In the realm of medical diagnostics, Folate-PEG3-amine emerges as a critical component for enhanced tumor detection. Through conjugation with imaging agents, Folate-PEG3-amine facilitates accurate tumor localization in imaging modalities such as PET and fluorescence imaging. This strategic coupling not only improves tumor visualization but also aids in early cancer detection and treatment planning, showcasing the transformative potential of this compound in diagnostic medicine.

Functional Nanoparticles: Folate-PEG3-amine assumes a pivotal role in the development of functionalized nanoparticles for diverse biomedical applications. By coating nanoparticles with Folate-PEG3-amine, researchers engineer systems that precisely target and deliver therapeutic agents to specific cell types, revolutionizing drug delivery strategies. This sophisticated functionalization approach enhances the specificity and efficiency of nanoparticle-based therapies.

Bioconjugation Research: Renowned for its versatility, Folate-PEG3-amine finds extensive utility in bioconjugation research, facilitating the linking of biomolecules such as peptides, proteins, and antibodies to targeting moieties or therapeutic agents. The inclusion of the PEG3 spacer imparts flexibility and reduces steric hindrance, enabling efficient binding and interactions. This application plays a crucial role in the creation of multifunctional bioconjugates for both research and therapeutic applications.

What is Folate-PEG3-amine used for in targeted ADCs?

Folate-PEG3-amine is a functional linker that targets folate receptor-expressing cells. The PEG3 spacer improves solubility and reduces steric hindrance, while the terminal amine provides a reactive site for conjugation with cytotoxins or imaging agents in ADC development.

2/7/2017

Dear team, how does Folate-PEG3-amine achieve cell-specific targeting?

The folate moiety binds specifically to folate receptors, which are overexpressed in many tumor types. This selective binding facilitates receptor-mediated internalization of ADCs, enhancing targeted delivery of cytotoxic payloads to cancer cells.

12/3/2017

Dear team, what types of payloads can be linked to Folate-PEG3-amine?

The terminal amine reacts with activated esters or maleimide groups on payloads, allowing conjugation of small molecule drugs, imaging agents, or fluorophores. The PEG spacer ensures accessibility and reduces steric constraints during coupling.

21/12/2022

Dear BOC Sciences, what are the recommended storage conditions for Folate-PEG3-amine?

Store under desiccated conditions at low temperature to preserve chemical integrity. Protect from light and moisture to maintain the folate functionality and reactivity of the terminal amine for consistent conjugation performance.

7/8/2022

Dear team, what are the considerations for solubility and handling of Folate-PEG3-amine?

Folate-PEG3-amine is soluble in aqueous buffers and common organic solvents such as DMSO. Handling should minimize exposure to light and air to prevent oxidation. For long-term storage, maintain at -20°C in a desiccated container and avoid multiple freeze-thaw cycles to preserve functional amine groups for bioconjugation.

5/1/2017

— Dr. Olivia Brown, Medicinal Chemist (UK)

Folate-PEG3-amine enabled efficient targeting moiety incorporation into our ADC constructs.

21/12/2022

— Ms. Anna Schmidt, Biochemist (Germany)

Excellent solubility and stability allowed smooth multi-step synthesis.

5/1/2017

— Dr. William Parker, ADC Scientist (USA)

High purity and lot-to-lot consistency made synthesis predictable and reliable.

7/8/2022

— Dr. Elise Moreau, Senior Chemist (France)

Integration into our linker workflow was seamless, saving valuable development time.

2/7/2017

— Dr. Liam Fischer, Chemist (UK)

Folate-PEG3-amine facilitated novel ADC designs enhancing solubility and targeting.

— Dr. Robert Green, Medicinal Chemist (UK)

Folate-PEG3-amine enabled efficient targeting ligand conjugation for our delivery studies. Excellent purity and solubility facilitated our workflow.

12/3/2017

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: tert-butyl 1-(4-formylphenyl)-1-oxo-5,8,11-trioxa-2-azatridecan-13-oate | XMT-1519 conjugate-1 | Fmoc-D-Val-Cit-PAB | Azetidin-3-ol hydrochloride | Fmoc-Val-Cit-PAB | N-succinimidyl 4-(5-nitro-pyridin-2-yldithio)-pentanoate | Fmoc-Phe-Lys(Boc)-PAB-PNP | Paclitaxel | 5-azidopentanoic acid N-hydroxysuccinimide ester | Doxorubicin hydrochloride | Folate-PEG3-amine
Send Inquiry
Verification code
Inquiry Basket